Metoprolol dosage for tachycardia
Pro Research Analysisby 
Searched over 200M research papers
Metoprolol Dosage for Tachycardia: A Comprehensive Review
Introduction to Metoprolol and Tachycardia
Metoprolol, a cardioselective beta-adrenergic blocker, is widely used in the management of various types of tachycardia, including exercise-induced tachycardia, multifocal atrial tachycardia (MAT), and ventricular tachyarrhythmias. This article synthesizes the findings from multiple studies to provide a clear understanding of the effective dosages and outcomes of metoprolol in treating tachycardia.
Metoprolol Dosage for Exercise-Induced Tachycardia
Effective Dosages and Duration
Research indicates that metoprolol is effective in reducing exercise-induced tachycardia at various dosages. In a study comparing different doses, it was found that 50, 100, and 200 mg of metoprolol significantly reduced exercise tachycardia 2 hours post-administration. However, these effects were not sustained at 24 hours, except for the 400 mg dose, which still showed a reduction but was less effective compared to atenolol and sotalol at similar dosages .
Metoprolol for Multifocal Atrial Tachycardia (MAT)
Oral and Intravenous Administration
Metoprolol has shown efficacy in treating MAT, particularly in patients with severe cardiopulmonary illness. Oral administration of metoprolol at an average dose of 32.5 mg resulted in a significant slowing of heart rate, with many patients converting to sinus rhythm within hours. Intravenous administration at a mean dose of 6.5 mg provided even faster results, with conversion occurring in less than 10 minutes .
Comparative Efficacy
In a randomized, double-blind study, metoprolol was found to be more effective than verapamil in treating MAT. The study reported an 89% response rate for metoprolol compared to 44% for verapamil, with a significant reduction in ventricular rate . Another study confirmed these findings, showing that metoprolol effectively restored sinus rhythm in all patients within 1 to 3 hours of administration .
Metoprolol for Ventricular Tachyarrhythmias
Intravenous Administration
Intravenous metoprolol has been effective in managing ventricular tachyarrhythmias, including those occurring during acute myocardial infarction. A dose of 15 mg intravenously, followed by 200 mg daily, significantly reduced the incidence of ventricular fibrillation compared to placebo . Another study demonstrated that intravenous metoprolol at doses ranging from 0.06 to 0.17 mg/kg body weight effectively treated sinus tachycardia and ventricular dysrhythmias without notable side effects .
Long-Term Management
In patients with implantable cardioverter defibrillators (ICDs), metoprolol at an average daily dose of 104 mg significantly reduced the recurrence of ventricular tachycardia and ventricular fibrillation compared to d,l-sotalol .
Conclusion
Metoprolol is a versatile and effective beta-blocker for managing various forms of tachycardia. The optimal dosage varies depending on the type and severity of tachycardia, with higher doses required for sustained effects in exercise-induced tachycardia and lower doses proving effective for MAT and ventricular tachyarrhythmias. Both oral and intravenous administrations are effective, with intravenous administration providing more rapid results. These findings underscore the importance of tailored dosing regimens to achieve the best therapeutic outcomes.
Sources and full results
Most relevant research papers on this topic